The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy

<b>Background:</b> There is emerging evidence of an inverse association between prostatic inflammation (PI) and prostate cancer (PCa) diagnosis and outcome. The Irani score, a validated system that scores PI according to the grade of stromal infiltration (Irani G) and the aggressiveness...

Full description

Saved in:
Bibliographic Details
Main Authors: Ugo Giovanni Falagario, Francesca Sanguedolce, Angelo Cormio, Antonella Ninivaggi, Marco Finati, Francesco Guzzi, Gian Maria Busetto, Carlo Bettocchi, Daniele Castellani, Giuseppe Carrieri, Luigi Cormio
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/15/2/166
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588728391958528
author Ugo Giovanni Falagario
Francesca Sanguedolce
Angelo Cormio
Antonella Ninivaggi
Marco Finati
Francesco Guzzi
Gian Maria Busetto
Carlo Bettocchi
Daniele Castellani
Giuseppe Carrieri
Luigi Cormio
author_facet Ugo Giovanni Falagario
Francesca Sanguedolce
Angelo Cormio
Antonella Ninivaggi
Marco Finati
Francesco Guzzi
Gian Maria Busetto
Carlo Bettocchi
Daniele Castellani
Giuseppe Carrieri
Luigi Cormio
author_sort Ugo Giovanni Falagario
collection DOAJ
description <b>Background:</b> There is emerging evidence of an inverse association between prostatic inflammation (PI) and prostate cancer (PCa) diagnosis and outcome. The Irani score, a validated system that scores PI according to the grade of stromal infiltration (Irani G) and the aggressiveness of glandular infiltration (Irani A), has indeed been found to be inversely associated with PCa diagnosis and outcome, but the presence of two categories (G and A) makes the performance of this score suboptimal. This study aimed to determine whether a novel prostatic inflammation score (PIS) that combines Irani G and A scores better defined the risk of being diagnosed with PCa at prostate biopsy (PBx). <b>Methods:</b> Between January 2013 and December 2023, the Irani scores were routinely assessed on hematoxylin and eosin-stained PBx cores. The novel PIS was obtained by combining Irani G and A scores by their kernel distribution. PIS 1 included patients who scored G 0–1/A 0–1, PIS 2 those who scored G 2–3/A 0–1, and PIS 3 included those who scored G 0–3/A 2–3. Logistic regression analysis was used to test the association between the novel PIS and the risk of being diagnosed with PCa and clinically significant (cs) PCa at PBx. <b>Results:</b> Among the 4620 eligible patients, PCa and csPCa detection rate was 47% and 25%, respectively. Overall, 3088 (66.8%) had low Irani G and 4041 (87.5%) had low Irani A scores. Using PIS, 2971 (64%) were classified as PIS 1, 1070 (23%) as PIS 2, and 579 (13%) as PIS 3. Notably, almost one-quarter of patients had heterogeneous Irani features. Multivariable analysis pointed out a significant association between PIS and the risk of being diagnosed with PCa and csPCa; the higher the PIS, the lower the likelihood of such diagnoses. Limitations included the absence of external validation. <b>Conclusions:</b> The novel PIS, easily obtained during routine pathology examination, was significantly associated with the risk of being diagnosed with PCa and csPCa at PBx. While PI seems to be overall protective over PCa, the different types (stromal vs. glandular) of inflammation depicted by PIS seem to express a different risk.
format Article
id doaj-art-d1e497816ab14b01aceba61df22379e6
institution Kabale University
issn 2075-4418
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-d1e497816ab14b01aceba61df22379e62025-01-24T13:28:58ZengMDPI AGDiagnostics2075-44182025-01-0115216610.3390/diagnostics15020166The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate BiopsyUgo Giovanni Falagario0Francesca Sanguedolce1Angelo Cormio2Antonella Ninivaggi3Marco Finati4Francesco Guzzi5Gian Maria Busetto6Carlo Bettocchi7Daniele Castellani8Giuseppe Carrieri9Luigi Cormio10Department of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122 Foggia, ItalyPathology Unit, Policlinico Foggia, University of Foggia, 71122 Foggia, ItalyDepartment of Urology, Azienda Ospedaliero-Universitaria Ospedali Riuniti Di Ancona, Università Politecnica delle Marche, Via Conca 71, 60126 Ancona, ItalyDepartment of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122 Foggia, ItalyDepartment of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122 Foggia, ItalyDepartment of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122 Foggia, ItalyDepartment of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122 Foggia, ItalyDepartment of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122 Foggia, ItalyDepartment of Urology, Azienda Ospedaliero-Universitaria Ospedali Riuniti Di Ancona, Università Politecnica delle Marche, Via Conca 71, 60126 Ancona, ItalyDepartment of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122 Foggia, ItalyDepartment of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122 Foggia, Italy<b>Background:</b> There is emerging evidence of an inverse association between prostatic inflammation (PI) and prostate cancer (PCa) diagnosis and outcome. The Irani score, a validated system that scores PI according to the grade of stromal infiltration (Irani G) and the aggressiveness of glandular infiltration (Irani A), has indeed been found to be inversely associated with PCa diagnosis and outcome, but the presence of two categories (G and A) makes the performance of this score suboptimal. This study aimed to determine whether a novel prostatic inflammation score (PIS) that combines Irani G and A scores better defined the risk of being diagnosed with PCa at prostate biopsy (PBx). <b>Methods:</b> Between January 2013 and December 2023, the Irani scores were routinely assessed on hematoxylin and eosin-stained PBx cores. The novel PIS was obtained by combining Irani G and A scores by their kernel distribution. PIS 1 included patients who scored G 0–1/A 0–1, PIS 2 those who scored G 2–3/A 0–1, and PIS 3 included those who scored G 0–3/A 2–3. Logistic regression analysis was used to test the association between the novel PIS and the risk of being diagnosed with PCa and clinically significant (cs) PCa at PBx. <b>Results:</b> Among the 4620 eligible patients, PCa and csPCa detection rate was 47% and 25%, respectively. Overall, 3088 (66.8%) had low Irani G and 4041 (87.5%) had low Irani A scores. Using PIS, 2971 (64%) were classified as PIS 1, 1070 (23%) as PIS 2, and 579 (13%) as PIS 3. Notably, almost one-quarter of patients had heterogeneous Irani features. Multivariable analysis pointed out a significant association between PIS and the risk of being diagnosed with PCa and csPCa; the higher the PIS, the lower the likelihood of such diagnoses. Limitations included the absence of external validation. <b>Conclusions:</b> The novel PIS, easily obtained during routine pathology examination, was significantly associated with the risk of being diagnosed with PCa and csPCa at PBx. While PI seems to be overall protective over PCa, the different types (stromal vs. glandular) of inflammation depicted by PIS seem to express a different risk.https://www.mdpi.com/2075-4418/15/2/166prostate cancerprostatic inflammationprostate biopsylower urinary tract symptomsbenign prostatic obstruction
spellingShingle Ugo Giovanni Falagario
Francesca Sanguedolce
Angelo Cormio
Antonella Ninivaggi
Marco Finati
Francesco Guzzi
Gian Maria Busetto
Carlo Bettocchi
Daniele Castellani
Giuseppe Carrieri
Luigi Cormio
The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
Diagnostics
prostate cancer
prostatic inflammation
prostate biopsy
lower urinary tract symptoms
benign prostatic obstruction
title The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
title_full The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
title_fullStr The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
title_full_unstemmed The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
title_short The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
title_sort novel histological prostatic inflammation score helps defining the association between stromal and glandular inflammation with the risk of prostate cancer at prostate biopsy
topic prostate cancer
prostatic inflammation
prostate biopsy
lower urinary tract symptoms
benign prostatic obstruction
url https://www.mdpi.com/2075-4418/15/2/166
work_keys_str_mv AT ugogiovannifalagario thenovelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT francescasanguedolce thenovelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT angelocormio thenovelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT antonellaninivaggi thenovelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT marcofinati thenovelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT francescoguzzi thenovelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT gianmariabusetto thenovelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT carlobettocchi thenovelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT danielecastellani thenovelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT giuseppecarrieri thenovelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT luigicormio thenovelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT ugogiovannifalagario novelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT francescasanguedolce novelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT angelocormio novelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT antonellaninivaggi novelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT marcofinati novelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT francescoguzzi novelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT gianmariabusetto novelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT carlobettocchi novelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT danielecastellani novelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT giuseppecarrieri novelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy
AT luigicormio novelhistologicalprostaticinflammationscorehelpsdefiningtheassociationbetweenstromalandglandularinflammationwiththeriskofprostatecanceratprostatebiopsy